Related Experiment Videos

Comprehensive management of the CLL patient: a holistic approach

Tait D Shanafelt1, Neil E Kay

  • 1Mayo Clinic, 200 First Street, Stabile 6-28, Rochester, MN 55905-0001, USA.

Hematology. American Society of Hematology. Education Program
|November 21, 2007
PubMed

Insights

Managing B-chronic lymphocytic leukemia (CLL) is complex due to advances in diagnosis, prognosis, and novel treatments. This review offers a framework to integrate new knowledge for better patient care and quality of life (QOL).

Area of Science:

  • Hematology
  • Oncology
  • Clinical Medicine

Background:

  • The management of B-chronic lymphocytic leukemia (CLL) has become increasingly complex for clinicians.
  • Rapid advancements in diagnostics, prognostics, and understanding of the disease's natural history present challenges.
  • Recognizing clinical complications and addressing patient quality of life (QOL) are crucial aspects of CLL care.

Purpose of the Study:

  • To summarize recent advances in B-chronic lymphocytic leukemia (CLL) management.
  • To provide a framework for integrating new knowledge into routine hematologic practice.
  • To assist hematologists in navigating the complexities of CLL care.

Main Methods:

  • Literature review of recent advancements in CLL diagnosis and prognosis.
  • Synthesis of information on CLL natural history and clinical complications.
  • Analysis of novel treatment approaches and their impact on quality of life.

Main Results:

  • Diagnostic precision has significantly improved.
  • Prognostic prediction methods are more sophisticated.
  • A wide array of novel treatment options are now available, alongside a better understanding of QOL issues.

Conclusions:

  • Integrating recent scientific and clinical advances is essential for effective CLL management.
  • A structured approach is needed to address the evolving landscape of CLL care.
  • This review provides a framework to support hematologists in optimizing patient outcomes and quality of life.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...